309 related articles for article (PubMed ID: 34256832)
1. Glycemic control by umbilical cord-derived mesenchymal stem cells promotes effects of fasting-mimicking diet on type 2 diabetic mice.
Zhao N; Gao YF; Bao L; Lei J; An HX; Pu FX; Cheng RP; Chen J; Ni H; Sui BD; Ji FP; Hu CH
Stem Cell Res Ther; 2021 Jul; 12(1):395. PubMed ID: 34256832
[TBL] [Abstract][Full Text] [Related]
2. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
[TBL] [Abstract][Full Text] [Related]
3. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
[TBL] [Abstract][Full Text] [Related]
4. Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice.
Li B; Cheng Y; Yin Y; Xue J; Yu S; Gao J; Liu J; Zang L; Mu Y
Cytotherapy; 2021 Jun; 23(6):510-520. PubMed ID: 33736932
[TBL] [Abstract][Full Text] [Related]
5. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice.
Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y
Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
[TBL] [Abstract][Full Text] [Related]
7. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
[TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes.
Xue J; Gao J; Gu Y; Wang A; Yu S; Li B; Yin Y; Wang J; Su W; Zhang H; Ren W; Gu W; Lv Z; Mu Y; Cheng Y
Stem Cell Res Ther; 2022 Mar; 13(1):109. PubMed ID: 35313972
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring.
Zang L; Li Y; Hao H; Liu J; Zhang Q; Gao F; Wang H; Chen Y; Gu W; Du J; Meng J; Zhang S; Lyu Z; Dou J; Mu Y
Stem Cells Transl Med; 2023 Dec; 12(12):775-782. PubMed ID: 37738447
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
Yin Y; Hao H; Cheng Y; Zang L; Liu J; Gao J; Xue J; Xie Z; Zhang Q; Han W; Mu Y
Cell Death Dis; 2018 Jul; 9(7):760. PubMed ID: 29988034
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
13. Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice.
Li B; Cheng Y; Yu S; Zang L; Yin Y; Liu J; Zhang L; Mu Y
Stem Cells Int; 2019; 2019():8628027. PubMed ID: 31781248
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
15. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
17. [The impact of human umbilical cord-derived mesenchymal stem cells on the pancreatic function of type 2 diabetic mice and their regulatory role on NLRP3 inflammasomes].
Wang J; Yin YQ; Cheng Y; Li B; Su WL; Yu SY; Xue J; Gu YL; Zhang HX; Zhang LX; Zang L; Mu YM
Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1077-1084. PubMed ID: 37650181
[No Abstract] [Full Text] [Related]
18. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
[TBL] [Abstract][Full Text] [Related]
19. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
[TBL] [Abstract][Full Text] [Related]
20. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
Si Y; Zhao Y; Hao H; Liu J; Guo Y; Mu Y; Shen J; Cheng Y; Fu X; Han W
Diabetes; 2012 Jun; 61(6):1616-25. PubMed ID: 22618776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
